This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katial, R. K.
Right arrow Articles by Zollinger, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katial, R. K.
Right arrow Articles by Zollinger, W. D.

 Previous Article  |  Next Article 

Infection and Immunity, February 2002, p. 702-707, Vol. 70, No. 2
0019-9567/02/$04.00+0     DOI: 70.2.702-707.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Immunogenicity and Safety Testing of a Group B Intranasal Meningococcal Native Outer Membrane Vesicle Vaccine

Rohit K. Katial,1* Brenda L. Brandt,2 Ellen E. Moran,2 Stephen Marks,1 Victor Agnello,1 and Wendell D. Zollinger2

Walter Reed Army Medical Center, Washington, D.C. 20307,1 Walter Reed Army Institute of Research, Forest Glen, Maryland 209102

Received 18 June 2001/ Returned for modification 7 August 2001/ Accepted 31 October 2001

The presently licensed meningococcal vaccine is a tetravalent capsular polysaccharide vaccine that induces immunity to serogroups A, C, Y, and W-135 but not to group B, which causes nearly half of the meningitis cases in the United States. The purpose of this study was to evaluate the safety and immunogenicity of an intranasal native outer membrane vesicle (NOMV) vaccine prepared from a capsule negative strain of group B of Neisseria meningitidis. In this study all volunteers received the same dose of vaccine, but we evaluated two different immunization schedules and the oropharyngeal and intranasal routes of vaccine delivery, assessed nasal cytology for cellular infiltration, and measured antibody-secreting cells (enzyme-linked immunospot assay [ELISPOT]) as an early marker for systemic immune response. Additionally, both intranasal and serum vaccine-specific antibodies were measured as well as serum bactericidal activity. Four groups with a total of 42 subjects were immunized on days 0, 28, and 56. Group 3 received an additional dose on day 7. Group 2 subjects were immunized both intranasally and oropharyngeally. Group 4 received a different lot of vaccine. All groups received approximately 1,200 µg of vaccine per subject. Patients were evaluated for side effects. The vaccine was well tolerated without evidence of inflammation on nasal cytology. The group receiving the extra vaccine dose showed the maximum increase in bactericidal activity. Thirty of 42 subjects demonstrated an increase in meningococcus-specific intranasal immunoglobulin A (IgA) titers, while 23 of 42 demonstrated an increase in specific IgG titers. The group receiving vaccine intranasally and oropharyngeally showed the highest rise in intranasal titers for both IgA and IgG. Groups 1, 3, and 4 showed a significant increase in antibody-secreting cells on ELISPOT. Eighteen of 42 volunteers demonstrated a fourfold or greater rise in bactericidal titers, with 81% showing an increase over baseline. We have demonstrated the immunogenicity and safety of a group B lipopolysaccharide-containing, intranasal, NOMV vaccine.

* Corresponding author. Mailing address: Walter Reed Army Medical Center, Allergy-Immunology Clinic, 6900 Georgia Ave. NW, Washington, DC 20307. Phone: (202) 782-8085. Fax: (202) 782-7093. E-mail: rohit.katial{at}na.amedd.army.mil.

Editor: R. N. Moore

Infection and Immunity, February 2002, p. 702-707, Vol. 70, No. 2
0019-9567/02/$04.00+0     DOI: 70.2.702-707.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Staats, H. F., Alam, S. M., Scearce, R. M., Kirwan, S. M., Zhang, J. X., Gwinn, W. M., Haynes, B. F. (2007). In Vitro and In Vivo Characterization of Anthrax Anti-Protective Antigen and Anti-Lethal Factor Monoclonal Antibodies after Passive Transfer in a Mouse Lethal Toxin Challenge Model To Define Correlates of Immunity. Infect. Immun. 75: 5443-5452 [Abstract] [Full Text]  
  • Bertot, G. M., Restelli, M. A., Galanternik, L., Aranibar Urey, R. C., Valvano, M. A., Grinstein, S. (2007). Nasal Immunization with Burkholderia multivorans Outer Membrane Proteins and the Mucosal Adjuvant Adamantylamide Dipeptide Confers Efficient Protection against Experimental Lung Infections with B. multivorans and B. cenocepacia. Infect. Immun. 75: 2740-2752 [Abstract] [Full Text]  
  • Grabenstein, J. D., Pittman, P. R., Greenwood, J. T., Engler, R. J.M. (2006). Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects. Epidemiol Rev 28: 3-26 [Abstract] [Full Text]  
  • Huo, Z., Sinha, R., McNeela, E. A., Borrow, R., Giemza, R., Cosgrove, C., Heath, P. T., Mills, K. H. G., Rappuoli, R., Griffin, G. E., Lewis, D. J. M. (2005). Induction of Protective Serum Meningococcal Bactericidal and Diphtheria-Neutralizing Antibodies and Mucosal Immunoglobulin A in Volunteers by Nasal Insufflations of the Neisseria meningitidis Serogroup C Polysaccharide-CRM197 Conjugate Vaccine Mixed with Chitosan. Infect. Immun. 73: 8256-8265 [Abstract] [Full Text]  
  • Shoemaker, D. R., Saunders, N. B., Brandt, B. L., Moran, E. E., LaClair, A. D., Zollinger, W. D. (2005). Intranasal Delivery of Group B Meningococcal Native Outer Membrane Vesicle Vaccine Induces Local Mucosal and Serum Bactericidal Antibody Responses in Rabbits. Infect. Immun. 73: 5031-5038 [Abstract] [Full Text]  
  • Fisseha, M., Chen, P., Brandt, B., Kijek, T., Moran, E., Zollinger, W. (2005). Characterization of Native Outer Membrane Vesicles from lpxL Mutant Strains of Neisseria meningitidis for Use in Parenteral Vaccination. Infect. Immun. 73: 4070-4080 [Abstract] [Full Text]  
  • Guthrie, T., Wong, S. Y. C., Liang, B., Hyland, L., Hou, S., Hoiby, E. A., Andersen, S. R. (2004). Local and Systemic Antibody Responses in Mice Immunized Intranasally with Native and Detergent-Extracted Outer Membrane Vesicles from Neisseria meningitidis. Infect. Immun. 72: 2528-2537 [Abstract] [Full Text]  
  • Mills, K. H. G., Cosgrove, C., McNeela, E. A., Sexton, A., Giemza, R., Jabbal-Gill, I., Church, A., Lin, W., Illum, L., Podda, A., Rappuoli, R., Pizza, M., Griffin, G. E., Lewis, D. J. M. (2003). Protective Levels of Diphtheria-Neutralizing Antibody Induced in Healthy Volunteers by Unilateral Priming-Boosting Intranasal Immunization Associated with Restricted Ipsilateral Mucosal Secretory Immunoglobulin A. Infect. Immun. 71: 726-732 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»